A review of six placebo-managed scientific trials with one,134 total members concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) have been related to a higher ordinary enhancement within the Ashworth scale for spasticity in numerous sclerosis patients compared with placebo, Whilst this did not reach statistical importance. Some those with PTSD https://jeremye851xrk0.wikistatement.com/user